||This article may be too technical for most readers to understand. (February 2017) (Learn how and when to remove this template message)|
The striatum (also the neostriatum and the striate nucleus) is one of the nuclei in the subcortical basal ganglia of the forebrain. The striatum is a critical component of the motor and reward systems; receives glutamatergic and dopaminergic inputs from different sources; and serves as the primary input to the rest of the basal ganglia nuclei.
purple=caudate and putamen, orange=thalamus
|Part of||Basal ganglia
|Anatomical terms of neuroanatomy|
Functionally, the striatum coordinates multiple aspects of cognition, including motor- and action- planning, decision-making, motivation, reinforcement, and reward perception. Structurally, when the globus pallidus (pale globe) is included with the striatum, they form the corpus striatum structure. The lentiform nucleus refers to the putamen of the dorsal striatum and the globus pallidus.
In primates, the striatum is divided into ventral and dorsal subdivisions, based upon function and connections. The ventral striatum consists of the nucleus accumbens and the olfactory tubercle. The dorsal striatum consists of the caudate nucleus and the putamen. A white matter, nerve tract (the internal capsule) in the dorsal part separates the caudate nucleus and the putamen. Anatomically, the term striatum describes the striped (striated) appearance of the grey-and-white matter that composes said structure of the brain.
The ventral striatum is composed of the nucleus accumbens and the olfactory tubercle. The nucleus accumbens is made up of the nucleus accumbens core and nucleus accumbens shell, which differ by neuron populations. The olfactory tubercle receives input from the olfactory bulb but has not been shown to play a role in processing smell. In non-primate species, the islands of Calleja are included. The ventral striatum is associated with the limbic system and has been implicated as a vital part of the circuitry for decision making and reward-related behavior.
The dorsal striatum is composed of the caudate nucleus and the putamen. Staining can differentiate the dorsal striatum into compartments of striosomes and surrounding matrix; this is particularly evident on the components of acetylcholinesterase and calbindin.
Types of cells in the striatum include:
- Medium spiny neurons, which are the principal neurons of the striatum. They are GABAergic and, thus, are classified as inhibitory neurons. Medium spiny projection neurons comprise 95% of the total neuronal population of the human striatum. Medium spiny neurons have two primary phenotypes (i.e., characteristic types): D1-type MSNs of the direct pathway and D2-type MSNs of the indirect pathway. A subpopulation of MSNs contain both D1-type and D2-type receptors, with approximately 40% of striatal MSNs expressing both DRD1 and DRD2 mRNA.
- Cholinergic interneurons release acetylcholine, which has a variety of important effects in the striatum. In humans, other primates, and rodents, these interneurons respond to salient environmental stimuli with stereotyped responses that are temporally aligned with the responses of dopaminergic neurons of the substantia nigra. The large aspiny cholinergic interneurons themselves are affected by dopamine through dopamine receptors D5.
- There are many types of GABAergic interneurons. The best known are parvalbumin expressing interneurons, also known as fast-spiking interneurons, which participate in powerful feedforward inhibition of principal neurons. Also, there are GABAergic interneurons that express tyrosine hydroxylase, somatostatin, nitric oxide synthase and neuropeptide-y. Recently, two types of neuropeptide-y expressing GABAergic interneurons have been described in detail, one of which translates synchronous activity of cholinergic interneurons into inhibition of principal neurons. These neurons of the striatum are not distributed evenly.
There are two regions of neurogenesis in the brain – the subventricular zone in the lateral ventricles, and the dentate gyrus. Neuroblasts that form in the lateral ventricle adjacent to the striatum, integrate in the striatum. This has been noted in the human striatum following an ischemic stroke. Injury caused to the striatum stimulates the migration of neuroblasts from the subventricular zone, to the striatum, where they differentiate into adult neurons. The normal passage of SVZ neuroblasts is to the olfactory bulb but this traffic is diverted to the striatum after an ischemic stroke. However, few of the new developed neurons survive.
The largest connection is from the cortex, in terms of cell axons. Many parts of the neocortex innervate the dorsal striatum. The cortical pyramidal neurons projecting to the striatum are located in layers II-VI, with the most dense projections come from layer V. They end mainly on the dendritic spines of the spiny neurons. They are glutamatergic, exciting striatal neurons.
The ventral striatum receives direct input from multiple regions in the cerebral cortex and limbic structures such as the amygdala, thalamus, and hippocampus, as well as the entorhinal cortex and the inferior temporal gyrus. Its primary input is to the basal ganglia system. Additionally, the mesolimbic pathway projects from the ventral tegmental area to the nucleus accumbens of the ventral striatum.
Another well-known afferent is the nigrostriatal connection arising from the neurons of the substantia nigra pars compacta. While cortical axons synapse mainly on spine heads of spiny neurons, nigral axons synapse mainly on spine shafts. In primates, the thalamostriatal afferent comes from the central median-parafascicular complex of the thalamus (see primate basal ganglia system). This afferent is glutamatergic. The participation of truly intralaminar neurons is much more limited. The striatum also receives afferents from other elements of the basal ganglia such as the subthalamic nucleus (glutamatergic) or the external globus pallidus (GABAergic).
The primary outputs of the ventral striatum project to the ventral pallidum, then the medial dorsal nucleus of the thalamus, which is part of the frontostriatal circuit. Additionally, the ventral striatum projects to the globus pallidus, and substantia nigra pars reticulata. Some of its other outputs include projections to the extended amygdala, lateral hypothalamus, and pedunculopontine nucleus.
Striatal outputs from both the dorsal and ventral components are primarily composed of medium spiny neurons (MSNs), a type of projection neuron, which have two primary phenotypes: "indirect" MSNs that express D2-type receptors and "direct" MSNs that express D1-type receptors.
The basal ganglia core is made up of the striatum along with the regions to which it projects directly, via the striato-pallidonigral bundle. The striato-pallidonigral bundle is a very dense bundle of sparsely myelinated axons, giving a whitish appearance. This projection comprises successively the external globus pallidus (GPe), the internal globus pallidus (GPi), the pars compacta of the substantia nigra (SNc), and the pars reticulata of substantia nigra (SNr). The neurons of this projection are inhibited by GABAergic synapses from the dorsal striatum. Among these targets, the GPe does not send axons outside the system. Others send axons to the superior colliculus. Two others comprise the output to the thalamus, forming two separate channels: one through the internal segment of the globus pallidus to the ventral oralis nuclei of the thalamus and from there to the cortical supplementary motor area and another through the substantia nigra to the ventral anterior nuclei of the thalamus and from there to the frontal cortex and the oculomotor cortex.
The ventral striatum, and the nucleus accumbens in particular, primarily mediates reward cognition, reinforcement, and motivational salience, whereas the dorsal striatum primarily mediates cognition involving motor function, certain executive functions (e.g., inhibitory control), and stimulus-response learning; there is a small degree of overlap, as the dorsal striatum is also a component of the reward system that, along with the nucleus accumbens core, mediates the encoding of new motor programs associated with future reward acquisition (e.g., the conditioned motor response to a reward cue).
Metabotropic dopamine receptors are present both on spiny neurons and on cortical axon terminals. Second messenger cascades triggered by activation of these dopamine receptors can modulate pre- and postsynaptic function, both in the short term and in the long term. In humans, the striatum is activated by stimuli associated with reward, but also by aversive, novel, unexpected, or intense stimuli, and cues associated with such events. fMRI evidence suggests that the common property linking these stimuli, to which the striatum is reacting, is salience under the conditions of presentation. A number of other brain areas and circuits are also related to reward, such as frontal areas. Functional maps of the striatum reveal interactions with widely distributed regions of the cerebral cortex important to a diverse range of functions.
Parkinson's disease results in loss of dopaminergic innervation to the dorsal striatum (and other basal ganglia) and a cascade of consequences. Atrophy of the striatum is also involved in Huntington's disease, choreas, choreoathetosis, and dyskinesias.
Addiction, a disorder of the brain's reward system, arises through the overexpression of ΔFosB, a transcription factor, in the D1-type medium spiny neurons of the ventral striatum. ΔFosB is an inducible gene which is increasingly expressed in the nucleus accumbens as a result of repeatedly overdosing on an addictive drug or overexposure to other addictive stimuli.
There is seen to be an association between striatal expression of variants of the PDE10A gene and some bipolar disorder I patients. Variants of other genes, DISCI and GNAS, have been associated with type II bipolar disorder.
Dysfunction in the ventral striatum can lead to a variety of disorders, most notably, depression and obsessive-compulsive disorder. Because of its involvement in reward pathways, the ventral striatum has also been implicated in playing a critical role in addiction. It has been well established that the ventral striatum is strongly involved in mediating the reinforcing effects of drugs, especially stimulants, through dopaminergic stimulation.
In the seventeenth and eighteenth centuries, the term "corpus striatum" was used to designate many distinct, deep, infracortical elements of the hemisphere. In 1941, Cécile and Oskar Vogt simplified the nomenclature by proposing the term striatum for all elements built with striatal elements (see primate basal ganglia system): the caudate, the putamen, and the fundus striati, that ventral part linking the two preceding together ventrally to the inferior part of the internal capsule.
The term neostriatum was forged by comparative anatomists comparing the subcortical structures between vertebrates, because it was thought to be a phylogenetically newer section of the corpus striatum. The term is still used by some sources, including Medical Subject Headings.
In birds the striatum is called the paleostriatum augmentatum.
- "Basal ganglia". BrainInfo. Retrieved 16 August 2015.
- Yager LM, Garcia AF, Wunsch AM, Ferguson SM (August 2015). "The ins and outs of the striatum: Role in drug addiction". Neuroscience. 301: 529–541. PMC . PMID 26116518. doi:10.1016/j.neuroscience.2015.06.033.
[The striatum] receives dopaminergic inputs from the ventral tegmental area (VTA) and the substantia nigra (SNr) and glutamatergic inputs from several areas, including the cortex, hippocampus, amygdala, and thalamus (Swanson, 1982; Phillipson and Griffiths, 1985; Finch, 1996; Groenewegen et al., 1999; Britt et al., 2012). These glutamatergic inputs make contact on the heads of dendritic spines of the striatal GABAergic medium spiny projection neurons (MSNs) whereas dopaminergic inputs synapse onto the spine neck, allowing for an important and complex interaction between these two inputs in modulation of MSN activity ... It should also be noted that there is a small population of neurons in the NAc that coexpress both D1 and D2 receptors, though this is largely restricted to the NAc shell (Bertran- Gonzalez et al., 2008). ... Neurons in the NAc core and NAc shell subdivisions also differ functionally. The NAc core is involved in the processing of conditioned stimuli whereas the NAc shell is more important in the processing of unconditioned stimuli; Classically, these two striatal MSN populations are thought to have opposing effects on basal ganglia output. Activation of the dMSNs causes a net excitation of the thalamus resulting in a positive cortical feedback loop; thereby acting as a ‘go’ signal to initiate behavior. Activation of the iMSNs, however, causes a net inhibition of thalamic activity resulting in a negative cortical feedback loop and therefore serves as a ‘brake’ to inhibit behavior ... there is also mounting evidence that iMSNs play a role in motivation and addiction (Lobo and Nestler, 2011; Grueter et al., 2013). ... Together these data suggest that iMSNs normally act to restrain drug-taking behavior and recruitment of these neurons may in fact be protective against the development of compulsive drug use.
- Taylor SB, Lewis CR, Olive MF (February 2013). "The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans". Subst. Abuse Rehabil. 4: 29–43. PMC . PMID 24648786. doi:10.2147/SAR.S39684.
The DS (also referred to as the caudate-putamen in primates) is associated with transitions from goal-directed to habitual drug use, due in part to its role in stimulus–response learning.28,46 As described above, the initial rewarding and reinforcing effects of drugs of abuse are mediated by increases in extracellular DA in the NAc shell, and after continued drug use in the NAc core.47,48 After prolonged drug use, drug-associated cues produce increases in extracellular DA levels in the DS and not in the NAc.49 This lends to the notion that a shift in the relative engagement from the ventral to the dorsal striatum underlies the progression from initial, voluntary drug use to habitual and compulsive drug use.28 In addition to DA, recent evidence indicates that glutamatergic transmission in the DS is important for drug-induced adaptations and plasticity within the DS.50
- Ferré S, Lluís C, Justinova Z, Quiroz C, Orru M, Navarro G, Canela EI, Franco R, Goldberg SR (June 2010). "Adenosine-cannabinoid receptor interactions. Implications for striatal function". Br. J. Pharmacol. 160 (3): 443–453. PMC . PMID 20590556. doi:10.1111/j.1476-5381.2010.00723.x.
Two classes of MSNs, which are homogeneously distributed in the striatum, can be differentiated by their output connectivity and their expression of dopamine and adenosine receptors and neuropeptides. In the dorsal striatum (mostly represented by the nucleus caudate-putamen), enkephalinergic MSNs connect the striatum with the globus pallidus (lateral globus pallidus) and express the peptide enkephalin and a high density of dopamine D2 and adenosine A2A receptors (they also express adenosine A1 receptors), while dynorphinergic MSNs connect the striatum with the substantia nigra (pars compacta and reticulata) and the entopeduncular nucleus (medial globus pallidus) and express the peptides dynorphin and substance P and dopamine D1 and adenosine A1 but not A2A receptors ... These two different phenotypes of MSN are also present in the ventral striatum (mostly represented by the nucleus accumbens and the olfactory tubercle). However, although they are phenotypically equal to their dorsal counterparts, they have some differences in terms of connectivity. First, not only enkephalinergic but also dynorphinergic MSNs project to the ventral counterpart of the lateral globus pallidus, the ventral pallidum, which, in fact, has characteristics of both the lateral and medial globus pallidus in its afferent and efferent connectivity. In addition to the ventral pallidum, the medial globus pallidus and the substantia nigra-VTA, the ventral striatum sends projections to the extended amygdala, the lateral hypothalamus and the pedunculopontine tegmental nucleus. ... It is also important to mention that a small percentage of MSNs have a mixed phenotype and express both D1 and D2 receptors (Surmeier et al., 1996).
- "Corpus striatum". BrainInfo. Retrieved 16 August 2015.
- "DBS: The Basal Ganglia".
- "Striatum definition and meaning | Collins English Dictionary". www.collinsdictionary.com.
- Ubeda-Bañon I, Novejarque A, Mohedano-Moriano A, et al. (2007). "Projections from the posterolateral olfactory amygdala to the ventral striatum: neural basis for reinforcing properties of chemical stimuli". BMC Neurosci. 8: 103. PMC . PMID 18047654. doi:10.1186/1471-2202-8-103.
- "Ventral striatum - NeuroLex". neurolex.org. Retrieved 2015-12-12.
- "Ventral Striatum Definition - Medical Dictionary". medicaldictionary.net. Retrieved 2015-11-18.
- "Ventral Striatum -- Medical Definition". www.medilexicon.com. Retrieved 2015-11-18.
- Nishi A, Kuroiwa M, Shuto T (July 2011). "Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons". Front Neuroanat. 5: 43. PMC . PMID 21811441. doi:10.3389/fnana.2011.00043.
Dopamine plays critical roles in the regulation of psychomotor functions in the brain (Bromberg-Martin et al., 2010; Cools, 2011; Gerfen and Surmeier, 2011). The dopamine receptors are a superfamily of heptahelical G protein-coupled receptors, and are grouped into two categories, D1-like (D1, D5) and D2-like (D2, D3, D4) receptors, based on functional properties to stimulate adenylyl cyclase (AC) via Gs/olf and to inhibit AC via Gi/o, respectively ... It has been demonstrated that D1 receptors form the hetero-oligomer with D2 receptors, and that the D1–D2 receptor hetero-oligomer preferentially couples to Gq/PLC signaling (Rashid et al., 2007a,b). The expression of dopamine D1 and D2 receptors are largely segregated in direct and indirect pathway neurons in the dorsal striatum, respectively (Gerfen et al., 1990; Hersch et al., 1995; Heiman et al., 2008). However, some proportion of medium spiny neurons are known to expresses both D1 and D2 receptors (Hersch et al., 1995). Gene expression analysis using single cell RT-PCR technique estimated that 40% of medium spiny neurons express both D1 and D2 receptor mRNA (Surmeier et al., 1996).
- Goldberg, JA; Reynolds, JN (December 2011). "Spontaneous firing and evoked pauses in the tonically active cholinergic interneurons of the striatum.". Neuroscience. 198: 27–43. PMID 21925242. doi:10.1016/j.neuroscience.2011.08.067.
- Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H (July 2004). "Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons.". Neuron. 43 (1): 133–43. PMID 15233923. doi:10.1016/j.neuron.2004.06.012.
- Bergson, C; Mrzljak, L; Smiley, J. F.; Pappy, M; Levenson, R; Goldman-Rakic, P. S. (1995). "Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain". The Journal of neuroscience : the official journal of the Society for Neuroscience. 15 (12): 7821–36. PMID 8613722.
- Tepper JM, Tecuapetla F, Koós T, Ibáñez-Sandoval O. Front Neuroanat. 2010 Dec 29;4:150. doi: 10.3389/fnana.2010.00150. PMID 21228905
- Koós, T; Tepper, JM (May 1999). "Inhibitory control of neostriatal projection neurons by GABAergic interneurons.". Nat Neurosci. 2 (5): 467–72. PMID 10321252. doi:10.1038/8138.
- Ibáñez-Sandoval, O; Tecuapetla, F; Unal, B; Shah, F; Koós, T; Tepper, JM (2010). "Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum.". J Neurosci. 30 (20): 6999–7016. PMC . PMID 20484642. doi:10.1523/JNEUROSCI.5996-09.2010.
- Ibáñez-Sandoval, O; Tecuapetla, F; Unal, B; Shah, F; Koós, T; Tepper, JM (November 2011). "A novel functionally distinct subtype of striatal neuropeptide Y interneuron.". J Neurosci. 31 (46): 16757–69. PMC . PMID 22090502. doi:10.1523/JNEUROSCI.2628-11.2011.
- English DF, Ibanez-Sandoval O, Stark E, Tecuapetla F, Buzsáki G, Deisseroth K, Tepper JM, Koos T. Nat Neurosci. 2011 Dec 11;15(1):123-30. doi: 10.1038/nn.2984. PMID 22158514
- Ernst, Aurélie; Alkass, Kanar; Bernard, Samuel; Salehpour, Mehran; Perl, Shira; Tisdale, John; Possnert, Göran; Druid, Henrik; Frisén, Jonas (February 2014). "Neurogenesis in the Striatum of the Adult Human Brain". Cell. 156 (5): 1072–1083. PMID 24561062. doi:10.1016/j.cell.2014.01.044.
- Inta, D; Lang, U E; Borgwardt, S; Meyer-Lindenberg, A; Gass, P (16 February 2016). "Adult neurogenesis in the human striatum: possible implications for psychiatric disorders". Molecular Psychiatry. 21 (4): 446–447. doi:10.1038/mp.2016.8.
- Kernie, SG; Parent, JM (February 2010). "Forebrain neurogenesis after focal Ischemic and traumatic brain injury.". Neurobiology of disease. 37 (2): 267–74. PMC . PMID 19909815. doi:10.1016/j.nbd.2009.11.002.
- Yamashita, T; Ninomiya, M; Hernández Acosta, P; García-Verdugo, JM; Sunabori, T; Sakaguchi, M; Adachi, K; Kojima, T; Hirota, Y; Kawase, T; Araki, N; Abe, K; Okano, H; Sawamoto, K (14 June 2006). "Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum.". The Journal of neuroscience : the official journal of the Society for Neuroscience. 26 (24): 6627–36. PMID 16775151. doi:10.1523/jneurosci.0149-06.2006.
- Rosell A, Giménez-Amaya JM (1999). "Anatomical re-evaluation of the corticostriatal projections to the caudate nucleus: a retrograde labeling study in the cat". Neurosci Res. 34 (4): 257–69. PMID 10576548. doi:10.1016/S0168-0102(99)00060-7.
- "Ventral striatum - NeuroLex". neurolex.org. Retrieved 2015-12-12.
- "Icahn School of Medicine | Neuroscience Department | Nestler Lab | Brain Reward Pathways". neuroscience.mssm.edu. Retrieved 2015-12-12.
- Trevor W. Robbins; Barry J. Everitt (April 1992). "Functions of dopamine in the dorsal and ventral striatum". Seminars in Neuroscience. 4: 119–127. doi:10.1016/1044-5765(92)90010-Y.
- Malenka RC, Nestler EJ, Hyman SE (2009). Sydor A, Brown RY, eds. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 147–148, 321, 367, 376. ISBN 978-0-07-148127-4.
VTA DA neurons play a critical role in motivation, reward-related behavior (Chapter 15), attention, and multiple forms of memory. This organization of the DA system, wide projection from a limited number of cell bodies, permits coordinated responses to potent new rewards. Thus, acting in diverse terminal fields, dopamine confers motivational salience (“wanting”) on the reward itself or associated cues (nucleus accumbens shell region), updates the value placed on different goals in light of this new experience (orbital prefrontal cortex), helps consolidate multiple forms of memory (amygdala and hippocampus), and encodes new motor programs that will facilitate obtaining this reward in the future (nucleus accumbens core region and dorsal striatum). In this example, dopamine modulates the processing of sensorimotor information in diverse neural circuits to maximize the ability of the organism to obtain future rewards. ...
Functional neuroimaging in humans demonstrates activation of the prefrontal cortex and caudate nucleus (part of the striatum) in tasks that demand inhibitory control of behavior. ...
The brain reward circuitry that is targeted by addictive drugs normally mediates the pleasure and strengthening of behaviors associated with natural reinforcers, such as food, water, and sexual contact. Dopamine neurons in the VTA are activated by food and water, and dopamine release in the NAc is stimulated by the presence of natural reinforcers, such as food, water, or a sexual partner. ...
The NAc and VTA are central components of the circuitry underlying reward and memory of reward. As previously mentioned, the activity of dopaminergic neurons in the VTA appears to be linked to reward prediction. The NAc is involved in learning associated with reinforcement and the modulation of motoric responses to stimuli that satisfy internal homeostatic needs. The shell of the NAc appears to be particularly important to initial drug actions within reward circuitry; addictive drugs appear to have a greater effect on dopamine release in the shell than in the core of the NAc.
- Greengard, P (2001). "The neurobiology of slow synaptic transmission". Science. 294 (5544): 1024–30. PMID 11691979. doi:10.1126/science.294.5544.1024.
- Cachope, R; Cheer (2014). "Local control of striatal dopamine release". Frontiers in Behavioral Neuroscience. 8: 188. PMC . PMID 24904339. doi:10.3389/fnbeh.2014.00188.
- Volman, S. F.; Lammel; Margolis; Kim; Richard; Roitman; Lobo (2013). "New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system". Journal of Neuroscience. 33 (45): 17569–76. PMC . PMID 24198347. doi:10.1523/JNEUROSCI.3250-13.2013.
- LUNA, BEATRIZ; SWEENEY, JOHN A. (1 June 2004). "The Emergence of Collaborative Brain Function: fMRI Studies of the Development of Response Inhibition". Annals of the New York Academy of Sciences. 1021 (1): 296–309. PMID 15251900. doi:10.1196/annals.1308.035.
- "Department of Physiology, Development and Neuroscience: About the Department".
- Choi EY, Yeo BT, Buckner RL (2012). "The organization of the human striatum estimated by intrinsic functional connectivity". Journal of Neurophysiology. 108 (8): 2242–2263. PMC . PMID 22832566. doi:10.1152/jn.00270.2012.
- Walker FO (January 2007). "Huntington's disease". Lancet. 369 (9557): 218–28. PMID 17240289. doi:10.1016/S0140-6736(07)60111-1.
- Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues Clin. Neurosci. 15 (4): 431–443. PMC . PMID 24459410.
- Olsen CM (Dec 2011). "Natural rewards, neuroplasticity, and non-drug addictions". Neuropharmacology. 61 (7): 1109–22. PMC . PMID 21459101. doi:10.1016/j.neuropharm.2011.03.010.
- McDonald, M-L; MacMullen, C; Liu, D J; Leal, S M; Davis, R L (October 2012). "Genetic association of cyclic AMP signaling genes with bipolar disorder". Translational Psychiatry. 2 (10): e169. doi:10.1038/tp.2012.92.
- Everitt, Barry J.; Robbins, Trevor W. (2013-11-01). "From the ventral to the dorsal striatum: Devolving views of their roles in drug addiction". Neuroscience & Biobehavioral Reviews. Honoring Ann Kelley. 37 (9, Part A): 1946–1954. doi:10.1016/j.neubiorev.2013.02.010.
- Raymond Vieussens, 1685
- Neostriatum at the US National Library of Medicine Medical Subject Headings (MeSH)
|Wikimedia Commons has media related to Striatum.|
- Stained brain slice images which include the "striatum" at the BrainMaps project
- hier-207 at NeuroNames
- Corpus Striatum at the US National Library of Medicine Medical Subject Headings (MeSH)